☰

Jennifer A. Hendrix, Ph.D. - Publications

Affiliations: 
2004 University of Virginia, Charlottesville, VA 
Area:
Animal Physiology Biology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

2/15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 Hendrix JA, Wamhoff BR, McDonald OG, Sinha S, Yoshida T, Owens GK. 5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo. The Journal of Clinical Investigation. 115: 418-27. PMID 15690088 DOI: 10.1172/Jci22648  0.353
2003 Kumar MS, Hendrix JA, Johnson AD, Owens GK. Smooth muscle alpha-actin gene requires two E-boxes for proper expression in vivo and is a target of class I basic helix-loop-helix proteins. Circulation Research. 92: 840-7. PMID 12663487 DOI: 10.1161/01.Res.0000069031.55281.7C  0.479
Low-probability matches (unlikely to be authored by this person)
2013 Gao Z, Hurst WJ, Guillot E, Czechtizky W, Lukasczyk U, Nagorny R, Pruniaux MP, Schwink L, Sanchez JA, Stengelin S, Tang L, Winkler I, Hendrix JA, George PG. Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I). Bioorganic & Medicinal Chemistry Letters. 23: 3416-20. PMID 23591110 DOI: 10.1016/j.bmcl.2013.03.080  0.103
2015 Gao Z, Hurst WJ, Hall D, Hartung R, Reynolds W, Kang J, Nagorny R, Hendrix JA, George PG. Design and synthesis of a novel series of histamine H3 receptor antagonists through a scaffold hopping strategy. Bioorganic & Medicinal Chemistry. 23: 429-38. PMID 25577710 DOI: 10.1016/j.bmc.2014.12.036  0.095
2013 Gao Z, Hurst WJ, Guillot E, Nagorny R, Pruniaux MP, Hendrix JA, George PG. Synthesis, characterization, and biological assessment of the four stereoisomers of the H(3) receptor antagonist 5-fluoro-2-methyl-N-[2-methyl-4-(2-methyl[1,3']bipyrrolidinyl-1'-yl)phenyl]benzamide. Bioorganic & Medicinal Chemistry Letters. 23: 4044-7. PMID 23769643 DOI: 10.1016/j.bmcl.2013.05.068  0.083
2013 Gao Z, Hurst WJ, Guillot E, Czechtizky W, Lukasczyk U, Nagorny R, Pruniaux MP, Schwink L, Sanchez JA, Stengelin S, Tang L, Winkler I, Hendrix JA, George PG. Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II). Bioorganic & Medicinal Chemistry Letters. 23: 3421-6. PMID 23591112 DOI: 10.1016/j.bmcl.2013.03.081  0.074
2002 Hendrix JA, Shimshock SJ, Shutske GM, Tomer IV JD, Kapples KJ, Palermo MG, Corbett TJ, Vargas HM, Kafka S, Brooks KM, Laws-Ricker L, Lee DKH, De Lannoy I, Bordeleau M, Rizkalla G, et al. Synthesis and structure-activity relationship of the isoindolinyl benzisoxazolpiperidines as potent, selective, and orally active human dopamine D4 receptor antagonists Chembiochem. 3: 999-1009. PMID 12362366 DOI: 10.1002/1439-7633(20021004)3:10<999::AID-CBIC999>3.0.CO;2-A  0.071
1985 Riccitelli SD, Schlatterer RG, Hendrix JA, Williams GB, Eberhart RC. Albumin coatings resistant to shear-induced desorption Transactions - American Society For Artificial Internal Organs. 31: 250-256. PMID 3837452  0.068
2013 Gao Z, Hurst WJ, Czechtizky W, Hall D, Moindrot N, Nagorny R, Pichat P, Stefany D, Hendrix JA, George PG. Identification and profiling of 3,5-dimethyl-isoxazole-4-carboxylic acid [2-methyl-4-((2S,3'S)-2-methyl-[1,3']bipyrrolidinyl-1'-yl)phenyl] amide as histamine H(3) receptor antagonist for the treatment of depression. Bioorganic & Medicinal Chemistry Letters. 23: 6269-73. PMID 24139584 DOI: 10.1016/j.bmcl.2013.09.081  0.061
2016 Holtzman DM, Carrillo MC, Hendrix JA, Bain LJ, Catafau AM, Gault LM, Goedert M, Mandelkow E, Mandelkow EM, Miller DS, Ostrowitzki S, Polydoro M, Smith S, Wittmann M, Hutton M. Tau: From research to clinical development. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27154059 DOI: 10.1016/J.Jalz.2016.03.018  0.056
2013 Gao Z, Hurst WJ, Czechtizky W, Francon D, Griebel G, Nagorny R, Pichat P, Schwink L, Stengelin S, Hendrix JA, George PG. Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders. Bioorganic & Medicinal Chemistry Letters. 23: 6141-5. PMID 24076172 DOI: 10.1016/j.bmcl.2013.09.006  0.05
1980 Hayford JT, Danney MM, Hendrix JA, Thompson RG. Integrated concentration of growth hormone in juvenile-onset diabetes Diabetes. 29: 391-398. PMID 6991330  0.046
2016 Hendrix JA, Bateman RJ, Brashear HR, Duggan C, Carrillo MC, Bain LJ, DeMattos R, Katz RG, Ostrowitzki S, Siemers E, Sperling R, Vitolo OV. Challenges, solutions, and recommendations for Alzheimer's disease combination therapy. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27017906 DOI: 10.1016/J.Jalz.2016.02.007  0.04
2015 Hendrix JA, Finger B, Weiner MW, Frisoni GB, Iwatsubo T, Rowe CC, Kim SY, Guinjoan SM, Sevlever G, Carrillo MC. The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 850-9. PMID 26194318 DOI: 10.1016/J.Jalz.2015.05.008  0.025
1979 Thompson RG, Hayford JT, Hendrix JA. Triglyceride concentrations: The disaccharide effect Science. 206: 838-839. PMID 493983  0.022
Hide low-probability matches.